(5) Heterogeneity in the regulation of EAT inflammation: EAT inflammation is a crucial predisposing factor for AF, and GLP-1RAs differ in their capacity to regulate EAT inflammation
The Beneficiaries of GLP-1 Drugs Across Industries Health Insurers and the Cost of Obesity Source: McKinsey 4 Although weight loss has been the main focus in the analyses of these drugs so far, it is important to bear in mind that with them comes the improvement in other measurements of health, such as blood glucose levels, cardiovascular parameters, cholesterol and triglyceride levels
So it's a whole myriad, or maybe you could say that GLP-1 orchestrates a number of different neuronal populations to have these overall effects that reduce energy intake
By week 4 the appetite control wasn't as strong so I decided to take several days off, once I restarted not only was the appetite control back, but it was stronger too
In the STEP trials, nausea was most common in the first 20 weeks of treatment and declined significantly after that
